Tuesday, 23 July 2019

Merck's biosimilar to AbbVie's Humira wins FDA approval

The U.S. Food and Drug Administration approved Merck & Co Inc's biosimilar to AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, the health agency said on Tuesday.


No comments:

Post a Comment